ANA
DE LORENZO PINTO
Profesora asociada de Ciencias de la Salud
María
Sanjurjo Sáez
Publications by the researcher in collaboration with María Sanjurjo Sáez (22)
2024
-
Presence of metallic components in transdermal drug delivery systems and risk of skin burns
Farmacia Hospitalaria, Vol. 48, Núm. 3, pp. T129-T132
2023
-
Appropriateness of Empirical Antibiotic Therapy for Cervicitis and Urethritis Prescribed in the Emergency Department
Hospital Pharmacy, Vol. 58, Núm. 1, pp. 106-110
-
Hacia la excelencia en la atención farmacéutica al paciente quirúrgico
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 26-30
-
Presence of metallic components in transdermal drug delivery systems and risk of skin burns
Farmacia Hospitalaria
2022
-
PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort
Biomedicine and Pharmacotherapy, Vol. 146
2021
-
La importancia de los casos clínicos para la Farmacia Hospitalaria
Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 6, Núm. 2, pp. 1-1
2020
-
Promoting clinical pharmacy services through advanced medication review in the emergency department
European Journal of Hospital Pharmacy , Vol. 27, Núm. 2, pp. 73-77
2019
-
Cancellations of elective surgical procedures due to inadequate management of chronic medications
Journal of Clinical Pharmacy and Therapeutics, Vol. 44, Núm. 4, pp. 561-564
-
Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia
International Journal of Clinical Pharmacy, Vol. 41, Núm. 5, pp. 1143-1147
-
Thromboprophylaxis Management in Surgical Patients: The Efficacy of a Protocol in the Electronic Prescription Program
Quality management in health care, Vol. 28, Núm. 4, pp. 245-249
2018
-
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study
Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241
2017
-
Análisis de los resultados económicos y en salud de un programa dirigido a la reducción de hemorragia en pacientes con síndrome coronario agudo
Revista Espanola de Cardiologia, Vol. 70, Núm. 10, pp. 825-831
2016
-
Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration
Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 4, pp. 444-446
-
Level of concordance between two risk-assessment models for predicting venous thromboembolism in medical patients at admission
European Journal of Hospital Pharmacy , Vol. 23, Núm. 3, pp. 141-144
-
Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes
International Journal of Clinical Practice, Vol. 70, Núm. 2, pp. 156-162
-
The challenges of the loading dose
Drugs and Therapy Perspectives, Vol. 32, Núm. 10, pp. 447-448
2015
-
Impact of the endorse study results on thromboprophylaxis prescribing patterns in medical patients attending the Emergency Department
International Journal of Clinical Practice, Vol. 69, Núm. 1, pp. 81-86
-
Implementation of smart pump technology in a paediatric intensive care unit
Health Informatics Journal, Vol. 21, Núm. 3, pp. 209-222
-
La clave de las tres ’a’: Alternar analgesia al alta
Emergencias
2014
-
Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes
International Journal of Clinical Pharmacy, Vol. 36, Núm. 4, pp. 821-826